Congress trades in Enanta Pharmaceuticals (ENTA)
Healthcare · Biotechnology
1 member of Congress has disclosed 1 trade in Enanta Pharmaceuticals (ENTA) since 2023: 0 buys and 1 sale. The most recent was disclosed on Aug 13, 2023.
- Trades disclosed
- 1
- Members trading
- 1
- Buys / sells
- 0 / 1
- Reported value
- $1K–$15K
Who traded ENTA
MemberBuysSalesLast disclosed
- Rep. Daniel S. Goldman (D-NY-10)0 buys · 1 sale01Aug 13, 2023
All trades
DisclosedTradeAmount
- Aug 13, 2023$1K–$15K
Rep. Daniel S. Goldman (D-NY-10)
Sold (full) Enanta Pharmaceuticals ENTA
$1K–$15K · Traded Jul 12, 2023 · disclosed Aug 13, 2023
From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.